EMEA Public Statement on the Recommendation to suspend the marketing authorisation for Orlaam (Levaceetylmethadol) in the European Union 19 April 2001 News
Public statement on the recommendation to suspend the marketing authorisation for Orlaam (levacetylmethadol) in the European UnionReference Number: EMEA/8776/01 English (EN) (50.44 KB - PDF)First published: 19/04/2001 Last updated: 19/04/2001 View Share this page